alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 1 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 2 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 3 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 4 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 5 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 6 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 7 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 8 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 9 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 10 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 11 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 12 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 13 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 14 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 15 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 16 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 17 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 18 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 19 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 20 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 21 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 22 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 23 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 24 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 25 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 26 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 27 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 28 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 29 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 30 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 31 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 32 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 33 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 34 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 35 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 36 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 37 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 38 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 39 of 40
Case 1:07-cv-05867-PAC-RLE Document 76-6 Filed 11/20/2009 Page 40 of 40
# C_2019280EN.01001301.xml

| 19.8.2019 | EN | Official Journal of the European Union | C 280/13 |
| --- | --- | --- | --- |

19.8.2019

EN

Official Journal of the European Union

C 280/13

---

Order of the Court (Sixth Chamber) of 10 April 2019 (request for a preliminary ruling from the Tribunal Judicial da Comarca de Faro, Juízo do Trabalho de Portimão — Juiz 1– Portugal) — Rolibérica Lda v Autoridade para as Condições do Trabalho

(C-834/18) (1)

(Reference for a preliminary ruling - Article 99 of the Rules of Procedure of the Court of Justice - Road transport - Regulation (EC) No 561/2006 - Article 4(i) - Concept of ‘week’ - Weekly rest periods - Calculation methods)

(2019/C 280/16)

Language of the case: Portuguese

Referring court

Tribunal Judicial da Comarca de Faro, Juízo do Trabalho de Portimão — Juiz 1

Parties to the main proceedings

Applicant: Rolibérica Lda

Defendant: Autoridade para as Condições do Trabalho

Operative part of the order

Regulation (EC) No 561/2006, of the European Parliament and of the Council of 15 March 2006, on the harmonisation of certain social legislation relating to road transport and amending Council Regulations (EEC) No 3821/85 and (EC) No 2135/98 and repealing Council Regulation (EEC) No 3820/85, must be interpreted as meaning that ‘weekly rest period’, within the meaning of Article 8 of that regulation must not necessarily end in the course of the ‘week’, as defined in Article 4(i) of that regulation.

---

(1)  OJ C 112, 25.3.2019.

---
# C_2020279EN.01000401.xml

| 24.8.2020 | EN | Official Journal of the European Union | C 279/4 |
| --- | --- | --- | --- |

24.8.2020

EN

Official Journal of the European Union

C 279/4

---

Judgment of the Court (First Chamber) of 25 June 2020 — SC v Eulex Kosovo

(Case C-730/18 P) (1)

(Appeal - Arbitration clause - Staff of EU international missions - Internal competition - Non-renewal of a contract of employment - Measure separable from the contract)

(2020/C 279/05)

Language of the case: English

Parties

Appellant: SC (represented by: A. Kunst, Rechtsanwältin and L. Moro, avvocatessa)

Other party to the proceedings: Eulex Kosovo (represented by: E. Raoult, avocate)

Operative part of the judgment

The Court:

| 1. | Sets aside the order of the General Court of the European Union of 19 September 2018, SC v Eulex Kosovo (T-242/17, EU:T:2018:586); |
| --- | --- |

1.

Sets aside the order of the General Court of the European Union of 19 September 2018, SC v Eulex Kosovo (T-242/17, EU:T:2018:586);

| 2. | Refers the case back to the General Court of the European Union; |
| --- | --- |

2.

Refers the case back to the General Court of the European Union;

| 3. | Reserves the costs. |
| --- | --- |

3.

Reserves the costs.

---

(1)  OJ C 112, 25.3.2019.

---
# C_2019288EN.01003801.xml

| 26.8.2019 | EN | Official Journal of the European Union | C 288/38 |
| --- | --- | --- | --- |

26.8.2019

EN

Official Journal of the European Union

C 288/38

---

Order of the President of the Court of 17 April 2019 (request for a preliminary ruling from the Tribunal Superior de Justicia de Canarias — Spain) — Unión Insular de CC.OO. de Lanzarote v Swissport Spain Aviation Services Lanzarote S.L.

(Case C-167/18) (1)

(2019/C 288/46)

Language of the case: Spanish

The President has ordered that the case be removed from the register.

---

(1)  OJ C 211, 18.6.2018.

---
EXHIBIT  99.2

                             CERTIFICATE PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection  with  the  Annual  Report  (the  "Report") on the Form 10-KSB of
Tylerstone  Ventures  Corporation  (the "Company") for the year ended August 31,
2005,  as  filed with the Securities and Exchange Commission on the date hereof,
I,  Laurence  Stephenson,  Chief  Executive  Officer,  President  and  Director,
certify,  pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

1.   The Annual Report fully complies with the requirements of Section 13 (a) or
     15  (d)  of  the  Securities  and  Exchange  Act  of  1934, as amended; and

2.   The  information  contained  in  this Annual Report fairly presents, in all
     material  respects, the financial condition and results of operation of the
     Company.



Date:  October  24,  2005
                                              /s/  "Laurence  Stephenson"
                                              ---------------------------
                                                   Laurence  Stephenson
                                                Chief  Executive  Officer,
                                                 President  and  Director
# C_2019319EN.01001401.xml

| 23.9.2019 | EN | Official Journal of the European Union | C 319/14 |
| --- | --- | --- | --- |

23.9.2019

EN

Official Journal of the European Union

C 319/14

---

Judgment of the Court (First Chamber) of 29 July 2019 (request for a preliminary ruling from the Tribunale di Bari — Italy) — Criminal proceedings against Massimo Gambino, Shpetim Hyka

(Case C-38/18) (1)

(Reference for a preliminary ruling - Judicial cooperation in criminal matters - Directive 2012/29/EU - Minimum standards on the rights, support and protection of victims of crime - Articles 16 and 18 - Victim testimony before a criminal court of first instance - Change in the composition of the bench - Requirement for a victim to repeat his oral evidence at the request of one of the parties to the proceedings - Charter of Fundamental Rights of the European Union - Articles 47 and 48 - Right to a fair trial and rights of the defence - Principle of immediacy - Scope - Victim’s right to protection during criminal proceedings)

(2019/C 319/13)

Language of the case: Italian

Referring court

Tribunale di Bari

Parties in the main criminal proceedings

Massimo Gambino, Shpetim Hyka

Interveners: Procura della Repubblica presso il Tribunale di Bari, Ernesto Lappostato, Banca Carige SpA — Cassa di Risparmio di Genova e Imperia

Operative part of the judgment

Articles 16 and 18 of Directive 2012/29/EU of the European Parliament and of the Council of 25 October 2012 establishing minimum standards on the rights, support and protection of victims of crime, and replacing Council Framework Decision 2001/220/JHA must be interpreted as not precluding national legislation under which, where the victim of a crime has already given testimony before the bench of a criminal court of first instance and the composition of that bench is changed subsequently, the testimony of that victim must, in principle, be given before that bench in its new composition where one of the parties to the proceedings refuses to allow such a bench to rely on the written record of that victim’s first testimony.

---

(1)  OJ C 142, 23.4.2018.

---
|   | 1. | The      Report fully complies with requirements of section 13(a) or 15(d) of the      Securities Exchange Act of 1934;and |
|--------|----|----------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The      information contained in the Report fairly presents, in all material      respects, the financial condition and result of operations of the      Company. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | /s/  Justin      Craig           |   |
|--------|--------------------------------------------|--------|
|   | Justin      Craig                          |   |
|   | President      and Chief Financial Officer |   |
|   |                                       |   |
|   | May      13, 2009                     |   |

----
**Exhibit 32.1**

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report of RxBids (the “Company”) on Form 10-Q for the period ending June 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, **Mack Bradley**, Chief Executive Officer and Acting Principal Accounting Officer of the            Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

| /s/ | **MACK BRADLEY** |
|-----|------------------|

 

**Mack Bradley**

Chief Executive Officer

Acting Principal Accounting Officer

August 19, 2009

 

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its            staff upon request. The foregoing certifications are accompanying the Company's Form 10-Q solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C.
§1350 (as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002), I, the
undersigned Chief Financial Officer of National Presto Industries, Inc. (the
Company), hereby certify that the Quarterly Report on Form 10-Q of the Company
for the quarterly period ended October 3, 2004 (the Report) fully complies with
the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.

A signed original of
this written statement required by Section 906 has been provided to the Company and will
be retained by the Company and furnished to the SEC or its staff upon request.

|Date:   November 9, 2004 |  | /s/   R. F. Lieble                   | 
|------------------------ |  | ------------------------------------ | 
|                         |  |                                     
|                         |  | R. F. Lieble,Chief Financial Officer | 

---
Exhibit
32 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18
U.S.C. SECTION 1350)   In
connection with the Quarterly Report of ArtVentive Medical Group, Inc., a
Nevada corporation (the Company), on Form 10-Q for the third quarter
ending September 30, 2010, as filed with the Securities and Exchange Commission
(the Report), I, H. James Graham, President of the Company, certify, pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that
to my knowledge:  (1) The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the
Company.     /s/ H. James
Graham H. James Graham President, Chief
Accounting Officer  Dated: November 10,
2010       CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18
U.S.C. SECTION 1350)   In
connection with the Quarterly Report of ArtVentive Medical Group, Inc., a
Nevada corporation (the Company), on Form 10-Q for the third quarter
ending September 30, 2010, as filed with the Securities and Exchange Commission
(the Report), I, Leon Rudakov, CEO of the Company, certify, pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to
my knowledge:  (1) The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the
Company.     /s/
Leon
Rudakov  Dr. Leon Rudakov,
CEO  Dated: November 10,
2010
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Agriculture

###### Agricultural Research Service 

# AGENCY:

Agricultural Research Service, USDA. 

# ACTION:

Notice of intent. 

# SUMMARY:

                        Notice is hereby given that the U.S. Department of Agriculture, Agricultural Research Service (USDA), intends to grant to Viral Therapeutics of Ithaca, New York, an exclusive license to the invention disclosed in U.S. Patent No. 6,017,713 issued on January 25, 2000, entitled “Ferritin Formation as a Predictor of Iron Availability in Foods.” Notice of Availability was published in the                         **Federal Register**                         on November 3, 1999.                     

# DATES:

Comments must be received on or before March 19, 2001. 

# ADDRESSES:

Send comments to: USDA, ARS, Office of Technology Transfer, 5601 Sunnyside Avenue, Rm. 4-1158, Beltsville, Maryland 20705-5131. 

# FOR FURTHER INFORMATION CONTACT:

June Blalock of the Office of Technology Transfer at the Beltsville address given above; telephone: 301-504-5989. 

# SUPPLEMENTARY INFORMATION:

The Federal Government's patent rights in this invention are assigned to the United States of America, as represented by the Secretary of Agriculture. It is in the public interest to so license the U.S. Government's rights in this invention as Viral Therapeutics has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within sixty (60) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. 

Richard M. Parry, Jr., 

Assistant Administrator. 

[FR Doc. 01-1265 Filed 1-16-01; 8:45 am] 

BILLING CODE 3410-03-P
**Exhibit 23.1**

Consent of Independent Registered Public Accounting Firm 

The Board of Directors 

Hennessy Advisors, Inc.: 

We hereby consent to the incorporation by referencein the Registration Statement on Form S-8 (No. 333-98203) of Hennessy Advisors, Inc. of our report dated October 27, 2006, regarding the balance sheets of Hennessy Advisors, Inc. as of September 30, 2006 and 2005, and related statements ofincome, stockholders’ equity, and cash flows for each of the two years ended September 30, 2006, into the annual report of Hennessy Advisors, Inc., being filed on Form 10-KSB. 

Stonefield Josephson, Inc. 

San Francisco, California 

December 5, 2006
**Exhibit 7.1**

**Quebecor Media Inc.**

**Statement Regarding Calculation of Ratio ofEarnings to Fixed Charges as Disclosed in**

**Quebecor Media Inc.’s Annual Report on Form 20-F for the YearEnded December 31, 2012**

For the purpose of calculating the ratio of earnings to fixed charges disclosed inQuebecor Media Inc.’s Annual Report on Form 20-F for the year ended December 31, 2012 under IFRS, (i) earnings consist of net income plus income taxes, fixed charges, amortized capitalized interest, less interest capitalized and(ii) fixed charges consist of interest expensed and capitalized, plus amortized premiums, discounts and financing fees amortization and an estimate of the interest within rental expense.
EXHIBIT 1

SPIKES Customer Volume Incentive Program

Program Purpose

The purpose of the SPIKES Customer Volume Incentive Program (the “Program”) is to enhance liquidity in

the products listed below. The resulting increase in liquidity on central limit order book liquidity benefits all 

participant segments in the market.

Product Scope

SPIKES Volatility Index Futures that are traded on MGEX via the CME Globex® trading platform 

(“Product”).

Eligible Participants

There is no limit to the number of participants in the Program. There are no member requirements for 

participants. Participants must complete an application with the Exchange to be eligible for the Program. 

An application can be received by contacting MGEX at mgex@mgex.com.

Program participants must not be Proprietary Trading Groups, which are defined by the CFTC as an 

organization whose owners, employees, and/or contractors trade in the name of accounts owned by the 

group and exclusively use the funds of the group for all of their trading activity. The Exchange, in its sole 

determination and based on a variety of factors, will have the final decision regarding disputes of eligibility.

Program Term

Start date is March 1, 2023. End date is June 30, 2023September 30, 2023.

Obligations

Upon meeting certain volume thresholds in the Product, participants will be eligible to receive 

predetermined incentives.

Incentives

Upon meeting all obligations, as determined by the Exchange, participants will be eligible to receive 

predetermined incentives.

Monitoring and Termination of Status

The Exchange will monitor trading activity and participants’ performance and retain the right to revoke 

participant status if it concludes from review that a participant no longer meets the eligibility requirements, 

fails to meet the obligations of the Program, or fails to comply with Exchange rules (including, but not limited 

to, rules relating to market manipulation, wash trades, etc.) or any applicable law.
Exhibit
32.2




CERTIFICATION
OF CO-CHIEF EXECUTIVE OFFICER


PURSUANT
TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002








I,
Michael A. Reisner, Co-Chief Executive Officer, Co-President of ICON Capital
Corp., the Manager of the Registrant, in connection with the Annual Report of
ICON Income Fund Nine, LLC (the “LLC”) on Form 10-K for the year ended December
31, 2008, as filed with the Securities and Exchange Commission on the date
hereof (the “Annual Report”) certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:




1.
              The
      Annual Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of
      1934, as amended; and
 
 2.
              The
      information contained in the Annual Report fairly presents, in all
      material respects, the  financial condition and results of operations
      of the LLC.







Date:
March 26, 2009








/s/Michael A.
Reisner


Michael
A. Reisner


Co-Chief
Executive Officer and Co-President


ICON
Capital Corp.


Manager
of ICON Income Fund Nine, LLC